About Sphaera Pharma
Sphaera Pharma is a Healthcare company based in Gurugram (India) founded in 2007. Specialty company engaged in drug discovery and development. Sphaera Pharma has raised $10 million across 2 funding rounds from investors including Wellcome and Baring Private Equity Partners. The company has 35 employees. Its Indian entity Sphaera Pharma Private Limited reported revenue of ₹7.73 Cr. Its focus areas include Diversified Pharmaceuticals.
Company details
Sphaera Pharma is engaged in drug discovery and development activities. All research programs are based on translational research. Sphaera has established a patent portfolio that includes repurposing of drugs, a potential solution focused on cancer metastasis, methodology that allows for designing therapies using current drugs to address resistant cancers, and potential treatment for multi-drug resistant infections Since, 2009, the company claims to have filed 28 patents. The pipeline includes a portfolio of 9 products in various preclinical and clinical stages.
- Headquarters Gurugram, India
- Employees 35
- SectorsHealthcare
- Email••••••••
- Website sphaerapharma.com
- Social LinkedIn
- Legal Name Sphaera Pharma Private Limited
- Date of Incorporation 30 Nov, 2007
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹7.73 Cr
FY 2024 · +6% YoY
- Net Profit₹1.3 Lakh
FY 2024 · 0% margin
- EBITDA₹23.8 Lakh
FY 2024 · 3% margin
- Total Equity Funding$10M (USD)
in 2 rounds
- InvestorsWellcome
& 1 more
- Employee Count35
Associated legal entities of Sphaera Pharma
Sphaera Pharma is associated with 2 registered companies on The Company Check; the primary company is Sphaera Pharma Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sphaera Pharma Private Limited CIN U24232DL2007PTC224934 | Active | 30 Nov 2007 | New Delhi, Delhi | ₹7.7 Cr | 43 | 4 | View details |
| Sphaera Pharma Research And Development Private Limited CIN U24232DL2008PTC224719 | Active | 28 Nov 2008 | New Delhi, Delhi | ₹0.0 Cr | 2 | View details |
Funding Insights of Sphaera Pharma
Sphaera Pharma has successfully raised a total of $10M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 2
- First Round $10M
(Nov 2008)
- Investors Count 2
All 2 funding rounds of Sphaera Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2015 | Grant | – | – | ||
| Nov 2008 | $10M | Series A | – | Baring Private Equity Partners | – |
2 investors in total: 2 institutional.
Investors in Sphaera Pharma
Sphaera Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Wellcome and Baring Private Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focusing on buyouts and investments in multiple sectors | 1998 | bpepindia.com | Mumbai, India | |
Health research and advocacy are funded globally by the foundation. | 1936 | wellcome.org | London, United Kingdom |
Investor details for Sphaera Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Sphaera Pharma Private Limited (Sphaera Pharma)
Sphaera Pharma Private Limited is the primary company behind Sphaera Pharma. The boards of the 2 registered companies of Sphaera Pharma currently have 3 directors; the longest-serving is Abhinav Dhandia, appointed in 2013. 28 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Abhinav Dhandia DIN 00456720 | Director | 08 Jan 2013 | 13 yrs 9 mo | Sphaera Pharma Research And Development Private Limited, Sphaera Pharma Private Limited |
| Ashish Dugar DIN 09810264 | Director | 02 Dec 2022 | 3 yrs 10 mo | Sphaera Pharma Research And Development Private Limited, Sphaera Pharma Private Limited |
| Somdutta Sen DIN 09202044 | Director | 02 Dec 2022 | 3 yrs 10 mo | Sphaera Pharma Private Limited |
People of Sphaera Pharma
2 people are tracked at Sphaera Pharma (1 in leadership, 1 in team); the tracked headcount is 35.
| Name | Role | Group |
|---|---|---|
Abhinav D. | Chief Executive Officer | Leadership |
Rajesh Babbar | Manager - Accounts & Commercial | Team |
Complete people profiles for Sphaera Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sphaera Pharma
Figures of Sphaera Pharma Private Limited, the primary company behind Sphaera Pharma, for FY 2024. Revenue was ₹7.73 Cr (+6% year on year). Net profit was ₹1.3 Lakh (0% margin). EBITDA was ₹23.8 Lakh (3% margin). Revenue has grown at a compounded annual rate of -13% over three years and +13% over five years.
- ₹7.73 CrRevenue · FY 2024 · +6% YoY
- ₹1.3 LakhNet profit · 0% margin
- ₹23.8 LakhEBITDA · 3% margin
- ₹9.25 CrPaid-up capital
- 43Employees (provident fund records)
- -13%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sphaera Pharma Private Limited are on its company page.
Detailed financial statements for Sphaera Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Sphaera Pharma
3 dated milestones of Sphaera Pharma across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Sphaera Pharma is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Grant,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sphaera Pharma
Complete news archive for Sphaera Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sphaera Pharma
Sphaera Pharma was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Sphaera Pharma is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Sphaera Pharma is a funded company, having raised a total of $10M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Nov 2008.
Sphaera Pharma has 35 employees.
The primary company behind Sphaera Pharma, Sphaera Pharma Private Limited, reported revenue of ₹7.73 Cr for FY 2024, up 6% year on year.
Sphaera Pharma is engaged in drug discovery and development activities. All research programs are based on translational research. Sphaera has established a patent portfolio that includes repurposing of drugs, a potential solution focused on cancer metastasis, methodology that allows for designing therapies using current drugs to address resistant cancers, and potential treatment for multi-drug resistant infections Since, 2009, the company claims to have filed 28 patents. The pipeline includes a portfolio of 9 products in various preclinical and clinical stages.
Sphaera Pharma has 2 investors. Key investors include Wellcome, and Baring Private Equity Partners.
Sphaera Pharma is associated with 2 legal entities: Sphaera Pharma Private Limited, Sphaera Pharma Research And Development Private Limited.
The legal entities of Sphaera Pharma currently have 4 directors, including Abhinav Dhandia, Ashish Dugar, Kritika Chhabra and others.